Getahun Molla Kassa, Aaron G. Lim, Melaku Tileku Tamiru, Tesfa Sewunet Alamneh, Peter Vickerman, Emebet Dagne, Andargachew Mulu, Obsie Baissa, Ora Paltiel, John F. Dillon, Elias Ali Yesuf, Matthew Hickman, Josephine G. Walker, Clare E. French, DESTINE NIHR Global Health Research Group
{"title":"Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa—An Analysis of Systematic Review Data","authors":"Getahun Molla Kassa, Aaron G. Lim, Melaku Tileku Tamiru, Tesfa Sewunet Alamneh, Peter Vickerman, Emebet Dagne, Andargachew Mulu, Obsie Baissa, Ora Paltiel, John F. Dillon, Elias Ali Yesuf, Matthew Hickman, Josephine G. Walker, Clare E. French, DESTINE NIHR Global Health Research Group","doi":"10.1111/jvh.70065","DOIUrl":null,"url":null,"abstract":"<p>Understanding risk factors for hepatitis C virus (HCV) is critical for targeting screening and prevention. We systematically reviewed risk factors associated with HCV seroprevalence among the general population in sub-Saharan Africa (SSA). Comprehensive systematic review of HCV seroprevalence of community-based observational studies reporting HCV risk factors in SSA. Study quality was assessed using Joanna Briggs Institute tool. Random effect meta-analyses were used to estimate odds ratios (OR) with 95% confidence intervals (CI). We identified 92 studies. Higher odds of HCV seroprevalence were observed among age 21–64 (OR = 1.77, 95% CI 1.17–2.68) and 65+ groups (OR = 11.75, 95% CI 5.51–25.05) compared to those aged ≤ 20 years; not being formally educated (OR = 1.78, 95% CI 1.35–2.35) compared to secondary/above and being married (OR = 1.91, 95% CI 1.45–2.51) or divorced (OR = 3.20, 95% CI 1.91–5.36) compared to never married. Family history of HCV (OR = 1.52, 95% CI 1.17–1.96), being a person living with HIV (OR = 2.64, 95% CI 1.61–4.33) or being HBsAg positive (OR = 1.66, 95% CI 1.10–2.50) were all positively associated with increased HCV seroprevalence, as was having a history of blood transfusion (OR = 1.81, 95% CI 1.33–2.45), hospitalisation (OR = 1.55, 95% CI 1.22–1.96), medical operation (OR = 1.28, 95% CI 1.01–1.62), scarification (OR = 1.29, 95% CI 1.01–1.64) and injection drug use (OR = 7.04, 95% CI 1.16–42.68). Pilot HCV screening programmes targeting older adults and people exposed to healthcare-associated factors could potentially lead to the efficient detection of HCV cases and reduce future HCV exposures among the general population in SSA countries.</p>","PeriodicalId":17762,"journal":{"name":"Journal of Viral Hepatitis","volume":"32 10","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jvh.70065","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Viral Hepatitis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jvh.70065","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Understanding risk factors for hepatitis C virus (HCV) is critical for targeting screening and prevention. We systematically reviewed risk factors associated with HCV seroprevalence among the general population in sub-Saharan Africa (SSA). Comprehensive systematic review of HCV seroprevalence of community-based observational studies reporting HCV risk factors in SSA. Study quality was assessed using Joanna Briggs Institute tool. Random effect meta-analyses were used to estimate odds ratios (OR) with 95% confidence intervals (CI). We identified 92 studies. Higher odds of HCV seroprevalence were observed among age 21–64 (OR = 1.77, 95% CI 1.17–2.68) and 65+ groups (OR = 11.75, 95% CI 5.51–25.05) compared to those aged ≤ 20 years; not being formally educated (OR = 1.78, 95% CI 1.35–2.35) compared to secondary/above and being married (OR = 1.91, 95% CI 1.45–2.51) or divorced (OR = 3.20, 95% CI 1.91–5.36) compared to never married. Family history of HCV (OR = 1.52, 95% CI 1.17–1.96), being a person living with HIV (OR = 2.64, 95% CI 1.61–4.33) or being HBsAg positive (OR = 1.66, 95% CI 1.10–2.50) were all positively associated with increased HCV seroprevalence, as was having a history of blood transfusion (OR = 1.81, 95% CI 1.33–2.45), hospitalisation (OR = 1.55, 95% CI 1.22–1.96), medical operation (OR = 1.28, 95% CI 1.01–1.62), scarification (OR = 1.29, 95% CI 1.01–1.64) and injection drug use (OR = 7.04, 95% CI 1.16–42.68). Pilot HCV screening programmes targeting older adults and people exposed to healthcare-associated factors could potentially lead to the efficient detection of HCV cases and reduce future HCV exposures among the general population in SSA countries.
期刊介绍:
The Journal of Viral Hepatitis publishes reviews, original work (full papers) and short, rapid communications in the area of viral hepatitis. It solicits these articles from epidemiologists, clinicians, pathologists, virologists and specialists in transfusion medicine working in the field, thereby bringing together in a single journal the important issues in this expanding speciality.
The Journal of Viral Hepatitis is a monthly journal, publishing reviews, original work (full papers) and short rapid communications in the area of viral hepatitis. It brings together in a single journal important issues in this rapidly expanding speciality including articles from:
virologists;
epidemiologists;
clinicians;
pathologists;
specialists in transfusion medicine.